TY - JOUR
T1 - Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis
AU - Longbrake, Erin E.
AU - Lancia, Samantha
AU - Tutlam, Nhial
AU - Trinkaus, Kathryn
AU - Naismith, Robert T.
N1 - Funding Information:
This investigator-initiated study was supported by Acorda Therapeutics. The authors had full independence in these baseline analyses and manuscript generation. It was also supported in part by NIH training grant UL1 TR000448 and NIH grant C06RR014513.
Funding Information:
Dr. Longbrake has received honoraria from speaking/consulting for Genzyme, Teva and Biogen. Her salary is supported by a Sylvia Lawry Physicians Fellowship (FP 1786-A-1) from the National MS Society.
Funding Information:
This grant was supported in part by NIH training grant UL1 TR000448 and NIH grant C06RR014513 and Dr. Longbrake is supported by a Sylvia Lawry Physician's Fellowship from the NMSS.
Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Background Visual dysfunction in MS can be quantified using a variety of tests. Many vision tests have not been formally evaluated among MS patients with existing visual dysfunction. Objective Evaluate several versions of visual acuity and contrast sensitivity tests, measures of central and peripheral vision, retina structure, electrophysiologic function, and quality of life among MS patients with moderate/severe visual dysfunction. Methods Cross-sectional study of 46 patients with stable, incompletely recovered optic neuritis. Testing included Snellen eye charts, several Sloan low contrast charts, Pelli Robson (PR) contrast sensitivity charts, optical coherence tomography, visual fields, Farnsworth Munsell 100-hue test, visual evoked potentials (VEP), and visual function quality of life (VFQ-25) testing. Results 98% of eyes could read two lines of the PR chart, while only 43% read the 2.5% contrast chart. Low contrast tests correlated strongly with each other and with retinal nerve fiber layer (RNFL) thickness, visual fields, and color vision but not with VEPs. For patients with RNFL <75 µm, VFQ-25 scores dropped by approximately 2 points for every 1 µm decrease in RNFL. Conclusion Among MS patients with visual impairment due to optic neuritis, PR contrast sensitivity could be utilized as a single chart. Visual quality of life was associated with RNFL thinning below 75 µm.
AB - Background Visual dysfunction in MS can be quantified using a variety of tests. Many vision tests have not been formally evaluated among MS patients with existing visual dysfunction. Objective Evaluate several versions of visual acuity and contrast sensitivity tests, measures of central and peripheral vision, retina structure, electrophysiologic function, and quality of life among MS patients with moderate/severe visual dysfunction. Methods Cross-sectional study of 46 patients with stable, incompletely recovered optic neuritis. Testing included Snellen eye charts, several Sloan low contrast charts, Pelli Robson (PR) contrast sensitivity charts, optical coherence tomography, visual fields, Farnsworth Munsell 100-hue test, visual evoked potentials (VEP), and visual function quality of life (VFQ-25) testing. Results 98% of eyes could read two lines of the PR chart, while only 43% read the 2.5% contrast chart. Low contrast tests correlated strongly with each other and with retinal nerve fiber layer (RNFL) thickness, visual fields, and color vision but not with VEPs. For patients with RNFL <75 µm, VFQ-25 scores dropped by approximately 2 points for every 1 µm decrease in RNFL. Conclusion Among MS patients with visual impairment due to optic neuritis, PR contrast sensitivity could be utilized as a single chart. Visual quality of life was associated with RNFL thinning below 75 µm.
KW - Multiple sclerosis
KW - Visual acuity
UR - https://www.scopus.com/pages/publications/84994868562
U2 - 10.1016/j.msard.2016.10.009
DO - 10.1016/j.msard.2016.10.009
M3 - Article
C2 - 27919490
AN - SCOPUS:84994868562
SN - 2211-0348
VL - 10
SP - 198
EP - 203
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
ER -